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ABSTRACT 
Objective: A simple, precise, accurate and specific high performance thin layer chromatographic method has been developed for the 
simultaneous estimation of zaltoprofen and paracetamol and Quantitation in pharmaceutical dosage form. 
Methods: The method employed silica gel 60F254 Precoated plates as stationary phase and a mixture of chloroform: acetone: toluene: 
acetic acid (6.5 :2.5:1:0.1v/v/v/v) as mobile phase. 
Results: The developed method was validated for accuracy, linearity, precision, specificity, limit of detection and limit of quantitation 
as per ICH guideline. The Rf value for ZLT and PCM were found to be 0.63±0.2 and 0.36±0.2 respectively. The calibration curve was 
found to be linear between 100-500 ng/spot for ZLT and 406.25-2031.25 ng/spot for PCM. The limit of detection and limit of 
quantitation for ZLT were found to be 13.45 and 40.78 ng/spot and for PCM 16.33 and 49.55 ng/spot respectively.  
Conclusion: The proposed method has been successfully applied for the estimation of Zaltoprofen and Paracetamol in their 
pharmaceutical formulation. 
KEYWORDS: Zaltoprofen (ZLT), Paracetamol(PCM), HPTLC, Method development, Validation. 
 
INTRODUCTION 
ZLT (Fig.1) and PCM(Fig.2) is a nonsteroidal anti-
inflammatory drug. Zaltoprofen is a prefentially COX-2 inhibitor 
and selectively inhibits prostaglandin E2 production at 
inflammatory sites and induce apoptosis in variety of cell lines3. 
While paracetamol is generally considered to be weak inhibitor 
of the synthesis of prostaglandins. It may act through inhibition 
of central nervous system cyclo-oxygenase (COX-3) isoform. 
Zaltoprofen and Paracetamol combination is used as a potent 
analgesic and anti-inflammatory drug in the pain management 
and increase the effect and decrease the dose dependent side 
effect. A survey of literature revealed that RPHPLC and UV-
visible spectrophotometric methods have been reported for 
estimation of Zaltoprofen and Paracetamol10-13. To the best of 
our knowledge there is no HPTLC methods reported for 
zaltoprofen and paracetamol in combined dosage form. So, the 
aim of work was to develop HPTLC method for simultaneous 
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estimation Zaltoprofen and Paracetamol and to validate the 
method as per ICH guidelines. 
 
Fig. 1: Structure of Zaltoprofen 
 
Fig. 2: Structure of Paracetamol 
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MATERIALS AND METHODS 
Reagents and chemicals: 
Zaltoprofen and Paracetamol were kindly supplied as a 
gift sample by Anlon healthcare Pvt. Ltd. Rajkot, India and Sun 
pharmaceuticals Pvt. Ltd. Silvassa, India Respectively. All other 
chemicals and reagents used were of AR grade and were 
purchased from CDH Chemicals, New Delhi, India.  
Instrumentation and chromatographic conditions: 
The sample were spotted in the form of bands of width 
8mm with a camag 100μL sample (Hamilton)syringe on 
Precoated silica gel aluminium pate 60 F254(10cm × 10cm) with 
250 μm thickness, E. Merk, Germany using a camag Linomat IV. 
The plates were prewashed by methanol and activated at 600C 
for 5min prior to chromatography. A constant application rate 
of 10 μL/spot was employed and space between two bands was 
6mm.The slit dimension was kept at 6 mm × 0.45 mm and 
10mm/s scanning speed was employed. The mobile phase 
consisted of chloroform: acetone: toluene: acetic acid 
(6.5:2.5:1:0.10v/v/v/v). The optimized chamber saturation time 
for mobile phase was 20 min at 270C±20C temperature. The TLC 
plate run distance was 80mm and TLC plates were dried and the 
densitometric scanning was performed on camag TLC scanner 3 
in the reflection/absorbance   mode at 269nm for all 
measurements and operated by CATS 4 software. the source of 
radiation utilized was deuterium lamp emitting a continuous UV 
spectrum between 190 and 400 nm. 
Standard solutions and calibration graphs: 
Stock solution was prepared by dissolving 0.08gm ZLT 
(800μg/ml) and 0.325gm of PCM (325μg/ml) in 100ml 
methanol. Working standard were prepared by diluting the 
stock solution in methanol and obtain concentrations of 10-50 
μg/ml of ZLT and 40.625-203.125 μg/ml of PCM. Each 
concentration was spotted five times on the TLC plate. The plate 
was developed on the chromatographic condition. The peak 
area was plotted against the concentration to obtain the 
calibration graphs. 
Validation of Developed Method: 
The developed method was validated as per the ICH 
guidelines Q2(R1) for linearity, accuracy, precision, limit of 
detection, limit of quantitation, specificity, and robustness. 
Linearity and Range: 
linearity of response for ZLT and PCM was assessed by 
analysis of five levels of calibration curve in the range of 100-
500 ng/spot for ZLT and 406.25-2035.25 ng/spot for PCM (n = 
5). 10μL of each solution were spotted on the TLC plate, plates 
were developed and analysed. 
Precision: 
Repeatability of sample application and Scanning: 
Repeatability of sample application and scanning was 
performed by application of 10μL of working standard solution 
of ZLT 30 μg/mL and PCM 121.875 μg/mL for six times on a 
same TLC plate and for scanning, scan six times without 
changing position of band. The plate was developed, dried and 
analysed as described in chromatographic condition. The area 
was measured and % RSD was calculated. 
Intermediate precision: 
Precision was carried out by spotting 10μL for three 
different concentrations (ZLT 10,30 and 50μg/mL and PCM 
40.625,121.875 and 203.126μg/mL) three times on same day 
for intraday precision and three times on different days for 
interday precision. Plate was developed and scanned. % RSD 
was calculated on the basis of peak area. 
Limit of detection and Limit of quantitation: 
The limits of detection and quantitation of the 
developed method were calculated from the standard deviation 
of the intercepts and mean slope of the calibration curves of ZLT 
and PCM using the formula as given below. 
LOD=3.3×σ /S and LOQ=10×σ /S 
Where, σ = Standard deviation of the Y intercept regress lines 
and S = Slope of the calibration curve equation. 
Specificity: 
The peak purity of Zaltoprofen and Paracetamol was 
determined by comparing the UV spectra of standard and 
sample (marketed formulation) scanned at peak start (S), peak 
apex(M) and peak end (E) position of band. 
Accuracy: 
Accuracy was determined by calculating recovery of 
both drug by standard addition method at three different level 
(80%,100% and 120%). From the test stock solution 
(ZLT:80μg/mL and PCM:325μg/mL) 2.5 mL was pippet out in 
four different 10mL volumetric flask and from the standard 
solution 2 ml for 80%, 2.5 mL for 100% and 3ml for 120% was 
added and in forth flask standard was not added and considered 
as 0% and make upto the mark with methanol. 
10μLof the above solution was spotted on TLC plate; 
plate was developed as mention in chromatographic conditions. 
The plate was dried and scanned. % recovery was calculated on 
the basis of peak area. 
Robustness: 
Robustness was determined by change in various 
parameter like change in mobile phase (±0.2mL acetone), 
saturation time(±2min), Run distance(±5mm) and detection 
wavelength (±2nm) were done by spotting 10μL solution of 
three concentrations (ZLT:10,30 and 50μg/mL and 
PCM:40.625,121.875 and 203.125μg/mL) on TLC plate three 
times and %RSD were calculated based on peak area. 
Assay of marketed formulation: 
Twenty tablets were weighed accurately and Powder 
equivalent to 325mg of PCM and 80mg of ZLT was transferred 
to 100 mL volumetric flask and dissolved in methanol and the 
volume was made upto the mark with methanol (3250 μg/ mL 
PCM and 80 μg/mL ZLT). 
From the above test stock solution 5mL was 
transferred in 50mL volumetric flask and diluted with methanol. 
Aliquots of 3.75mL from the above solution were pipetted out 
and transferred to 10 mL volumetric flasks in triplicate and 
made upto the mark with methanol. 10μL was spotted along 
with the standard solutions of different concentrations. The 
content of PCM and ZLT was calculated from the linear 
regression equation on the basis of peak area, SD and % assay 
was calculated. 
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RESULTS 
Optimization of chromatographic condition: 
The method employed silica gel 60F254 Precoated 
plates as stationary phase and a mixture of chloroform: acetone: 
toluene: acetic acid (6.5 :2.5:1:0.1v/v/v/v) as mobile phase 
provide optimum resolution of ZLT and PCM.The Rf value for 
ZLT and PCM were found to be 0.63±0.2 and 0.36±0.2 
respectively (figure 3). 
Linearity:  
Linear regression for calibration curve of Zaltoprofen 
was found to be 0.999 and for Paracetamol was found to be 
0.996. the regression line equation is as follows: (figure 3&4) 
y = 7.115x+496.3 for Zaltoprofen and y=3.838x+1917 for 
Paracetamol
  
         Fig. 3: Calibration curve of Zaltoprofen           Fig. 4: Calibration curve of Paracetamol 
 
Fig. 5: Standard chromatogram of ZLT and PCM 
Precision: 
The %RSD for peak area was found to be 0.17 and 0.43 
of Zaltoprofen and Paracetamol respectively by spot application 
six times. The %RSD for peak area was found to be 0.26 and 
0.31 of ZLT and PCM respectively by spot scanning six times. 
The %RSD for peak area was found to be 0.17 and 0.43 
of Zaltoprofen and Paracetamol respectively by spot application 
six times. The %RSD for peak area was found to be 0.26 and 
0.31 of ZLT and PCM respectively by spot scanning six times. 
The %RSD for intraday precision was found to be 0.62-
0.91for ZLT and 0.13-0.17 for PCM. Interday precision was 
performed by analyzing three different concentrations within 
linearity range, three times in different day. The %RSD for 
Interday precision was found to be 0.68-1.62 for ZLT and 0.55-
1.04 for PCM (Table 1&2). 
LOD and LOQ: 
The LOD and LOQ and were found to be 13.45, 40.78 
ng/spot and 16.33, 49.55 ng/spot respectively for Zaltoprofen 
and Paracetamol. 
Specificity: 
The peak purity of ZLT and PCM was assessed by 
comparing their respective spectra at peak start, peak apex and 
peak end positions of the spot, i.e. r (M, E) =0.999596, 0.999801. 
good correlation (r=0.999780 and r=0.99857) was obtained 
between standard and sample spectra of ZLT and PCM 
respectively. 
Accuracy: 
To check the accuracy of the method, recovery studies 
were carried out by addition of standard solution to sample 
solutions at three different levels, 80,100,120%. Chromatogram 
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was developed and % recovery was found to be 100.36% and 
100.05% for ZLT and PCM respectively (Table 3). 
Assay of marketed dosage form: 
The assay concentration was taken 300ng/spot for 
ZLT and 1218.75ng/spot for PCM.The drug content was found 
to be 101.60%±01.53 and 100.37%±00.54 for ZLT and PCM 
respectively. 
Robustness: 
Developed method was found to be robust by changing 
the parameter saturation time (±2min), detection wavelength 
(±2nm), mobile phase (±0.2ml of acetone) and run time (±5 
min) in 3 levels and % RSD was found to be below 2% (Table 
4&5) 
Table No. 1: Intraday data of ZLT and PCM 
Sr.no. Concentration 
(ng/spot) 
Average area(n=3)mean± SD %RSD 
Zaltoprofen 
1 100 1167.50±10.69 0.91 
2 300 2638.23±16.38 0.62 
3 500 4036.03±35.22 0.87 
Paracetamol 
1 406.25 3309.33±5.20 0.17 
2 1218.75 6755.830±9.11 0.13 
3 2031.25 9584.7±16.75 0.17 
Table No. 2: Interday data of ZLT and PCM 
Sr.no. Concentration 
(ng/spot) 
Average area(n=3)mean± SD %RSD 
Zaltoprofen 
1 100 1190.73±08.11 1.62 
2 300 2678.70±28.41 1.06 
3 500 4119.12±66.75 0.68 
Paracetamol 
1 406.25 3414.80±35.38 0.55 
2 1218.75 6825.46±44.55 0.65 
3 2031.25 9726.00±43.14 1.04 
Table No. 3: Accuracy data of Zaltoprofen and Paracetamol 
% Level Amount of Test 
(ng) 
Amount of 
Standard spike 
(ng) 
Amount of standard 
Recovered (ng)±SD 
% Recovered 
±SD 
% Avg. 
recovered 
Zaltoprofen 
80 200 160 158.87±13.43 99.29±08.93  
100 200 200 203.67±10.98 101.83±05.49 100.36 
120 200 240 239.98±03.18 99.99±01.32  
Paracetamol 
80 812.5 650.0 652.32±03.26 100.35±00.50  
100 812.5 812.5 807.85±14.35 99.42±01.77 100.05 
120 812.5 975.0 978.97±14.30 100.40±01.46  
Table No. 4: Robustness data of Zaltoprofen 
Parameter Mean area(n = 3) Mean ± SD %RSD 
 Optimized 
condition 
Changed condition   
- + 
Mobile 
phase(±0.2mL) 
1162.6 1152.63 1185.62 1166.95±16.91 1.44 
2652.9 2612.32 2715.02 2660.08±51.72 1.94 
3994.2 3889.96 4020.22 3968.12±68.93 1.73 
Saturation 
time(±2min) 
1162.6 1125.25 1160.36 1149.40±20.94 1.82 
2652.9 2612.02 2700.25 2655.05±44.15 1.66 
3994.2 3895.43 4045.66 3978.43±76.34 1.91 
Run 
distance(±5mm) 
1162.6 1135.25 1178.98 1158.94±22.09 1.90 
2652.9 2599.63 2702.36 2651.63±51.37 1.93 
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3994.2 3889.96 4012.88 3965.68±66.23 1.67 
Detection 
wavelength (±2nm) 
1162.6 1185.98 1200.87 1183.15±19.29 1.63 
2652.9 2612.00 2712.23 2659.04±50.39 1.89 
3994.2 3991.25 4112.52 4032.65±69.17 1.71 
Table No. 5: Robustness data of Paracetamol 
Parameter Mean area(n = 3) Mean ± SD %RSD 
 Optimized 
condition 
Changed condition   
- + 
Mobile 
phase(±0.2mL) 
3310.20 3299.89 3365.25 3325.11±35.13 1.05 
6752.06 6689.36 6920.93 6787.45±119.77 1.76 
9598.51 9512.22 9659.78 9590.16±74.13 0.77 
Saturation 
time(±2min) 
3310.20 3256.32 3378.94 3315.15±61.45 1.85 
6752.06 6894.80 6909.11 6851.95±86.79 1.26 
9598.51 9449.23 9664.52 9570.65±110.25 1.15 
Run 
distance(±5mm) 
3310.20 3275.42 3400.88 3328.83±64.77 1.94 
6752.06 6675.12 6908.63 6778.65±118.93 1.75 
9598.51 9453.26 9746.25 9599.23±146.49 1.52 
Detection 
wavelength (±2nm) 
3310.20 3272.51 3386.77 3323.16±58.22 1.75 
6752.06 6701.28 6885.37 6779.57±95.07 1.40 
9598.51 9538.53 9848.81 9661.84±164.63 1.70 
 
DISCUSSION 
Developed chromatographic method was validated 
according to ICH guidelines. Linearity study indicated that area 
was directly proportional to concentration (r2=0.999 for ZLT 
and r2=0.996 for PCM) and that the method was linear. % RSD 
for precision study was less than 2% showing that the method 
was precise. The LOD and LOQ for ZLT were found to be 13.45 
and 40.78 ng/spot and for PCM 16.33 and 49.55 ng/spot 
respectively. Recovery study was carried out at concentration 
level of 80%,100% and 120%. Mean % recovery was found to 
be 100.63 and   100.05 for ZLT and PCM respectively. In 
Robustness study, % RSD was found to be less than 2% 
indicating that small changes in parameter such as mobile 
phase, saturation time, run time and detection wavelength did 
not show any major changes in results. In quantitation of 
pharmaceutical dosage form % was found to be 101.60 and 
100.37 for ZLT and PCM respectively. 
CONCLUSION 
The developed HPTLC method provides simple, 
accurate and reproducible quantitative analysis for 
simultaneous determination of ZLT and PCM in tablets dosage 
form. The method was validated as per ICH guideline. 
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